Literature DB >> 5485721

Use of acetone-dried vaccines for preparing capsular antisera against the Klebsiella group and the lyophilization of Klebsiella cultures.

J H Green, N E Pigott, R C Bolin, W K Harrell.   

Abstract

Capsular antisera against the 72 types of Klebsiella have been prepared in rabbits by using an acetone-dried vaccine. It was shown that encapsulated cells dried with acetone and ground to a fine powder with a mortar and pestle retain their capsules. Antisera obtained from rabbits vaccinated with these vaccines had quellung titers ranging from 1:16 to 1:64. The dried vaccine was stable after storage for over 2 years at room temperature. Encapsulated cultures lyophilized in the presence of 5% sucrose, 5% sodium glutamate, and 5% polyvinylpyrrolidone remained viable and retained their capsules after storage for 10 months at room temperature.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5485721      PMCID: PMC376950          DOI: 10.1128/am.20.3.416-420.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Serological investigations in the Klebsiella group. I. New capsule types.

Authors:  I ØRSKOV
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  Studies on the Klebsiella-Aerobacter group of bacteria.

Authors:  P R EDWARDS; M A FIFE
Journal:  J Bacteriol       Date:  1955-10       Impact factor: 3.490

3.  A new Klebsiella type (capsular type 15) isolated from feces and urine.

Authors:  M T WORFEL; W W FERGUSON
Journal:  Am J Clin Pathol       Date:  1951-11       Impact factor: 2.493

4.  Capsule types of Klebsiella.

Authors:  P R EDWARDS; M A FIFE
Journal:  J Infect Dis       Date:  1952 Jul-Aug       Impact factor: 5.226

  4 in total
  4 in total

1.  Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.

Authors:  Madushini N Dharmasena; Manuel Osorio; Kazuyo Takeda; Scott Stibitz; Dennis J Kopecko
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

2.  Progress towards the development of Klebsiella vaccines.

Authors:  Myeongjin Choi; Sharon M Tennant; Raphael Simon; Alan S Cross
Journal:  Expert Rev Vaccines       Date:  2019-06-28       Impact factor: 5.217

3.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

4.  Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae.

Authors:  Gaowei Hu; Xue Chen; Wenhui Chu; Zhe Ma; Yingjie Miao; Xi Luo; Yongqian Fu
Journal:  Vet Res       Date:  2022-01-21       Impact factor: 3.683

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.